GlobeNewswire 2022-01-10 Denali Therapeutics Announces Progression and Expansion of Broad Therapeutic Portfolio for Neurodege...
GlobeNewswire 2021-11-17 Denali Therapeutics Announces Strategic Partner Takeda Exercises Option to Co-Develop and Co-Commerc...
GlobeNewswire 2021-11-04 Denali Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights
GlobeNewswire 2021-10-06 Denali Therapeutics Announces Positive Clinical Results and Regulatory Progress for Development Prog...
GlobeNewswire 2021-09-29 Denali Therapeutics Announces Upcoming Presentations on EIF2B Activator DNL343 and RIPK1 Inhibitor S...
GlobeNewswire 2021-09-27 Denali Therapeutics Appoints Katie Peng as Chief Commercial Officer
GlobeNewswire 2021-09-21 Biogen R&D Day to Provide Overview of Diversified Pipeline and Capabilities with Potential for Multi...
GlobeNewswire 2021-09-09 Denali Therapeutics Announces Initiation of Phase 1b Study of EIF2B Activator DNL343 in ALS
GlobeNewswire 2021-09-07 CENTOGENE Reports Second Quarter 2021 Financial Results
GlobeNewswire 2021-08-26 Denali Therapeutics Announces Publication in Cell on New Approach to Treat FTD-GRN
GlobeNewswire 2021-08-04 Denali Therapeutics Reports Second Quarter 2021 Financial Results and Business Highlights
GlobeNewswire 2021-08-03 Zymergen Provides Business Update
GlobeNewswire 2021-08-02 Allogene Therapeutics Appoints Industry Leaders Elizabeth (Liz) Barrett and Vicki Sato, Ph.D., to i...
GlobeNewswire 2021-07-25 Denali Therapeutics Announces Positive Interim Data from Phase 1/2 Study with ETV:IDS (DNL310) in Pa...
GlobeNewswire 2021-07-15 Denali Therapeutics to Present Interim Data from Phase 1/2 Study of ETV:IDS (DNL310) for the Potenti...
GlobeNewswire 2021-06-28 Denali Therapeutics Announces Initiation of Phase 2 Study by Partner Sanofi of RIPK1-Inhibitor DNL75...
GlobeNewswire 2021-05-17 F-star Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire 2021-05-10 CENTOGENE Extends Global Parkinson’s Disease Study
GlobeNewswire 2021-05-03 Denali Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights
GlobeNewswire 2021-05-01 Denali Therapeutics Presents Positive Results from Phase 1 and Phase 1b Studies of Its LRRK2 Inhibit...
GlobeNewswire 2021-04-15 CENTOGENE Reports Record Fourth Quarter and Full Year 2020 Financial Results
GlobeNewswire 2021-03-23 Athira Pharma to Participate in Panel and Corporate Presentations at Life Science Innovation Northwe...
GlobeNewswire 2021-03-11 Denali Therapeutics Announces Fast Track Designation Granted by the U.S. FDA to ETV:IDS (DNL310) for...
GlobeNewswire 2021-03-09 CENTOGENE Reaches 10,000 Participant Milestone in Global Parkinson’s Disease Study
GlobeNewswire 2021-02-25 Denali Therapeutics Reports Full Year 2020 Financial Results and Business Highlights